Abeona Therapeutics Inc vs Dollar General Corp. — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Dollar General Corp. trades at $120.1 (market cap $26.49B). The key difference: Dollar General Corp. is far larger — about 62.9× Abeona Therapeutics Inc's market cap, and Dollar General Corp. pays a 1.97% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | DG | |
|---|---|---|
Market Cap | $421.19M | $26.49B |
Sector | Health | Consumer Staples |
52-Week High | $7.45 | $156.26 |
52-Week Low | $4.17 | $95.94 |
Enterprise Value | $276.10M | $40.93B |
Dividend Yield | — | 1.97% |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →A leading American discount retailer, Dollar General operates over 18,000 stores in 47 states, selling branded and private-label products across a wide variety of categories. In fiscal 2021, 77% of net sales came from consumables (including paper and cleaning products, packaged and perishable food, tobacco, and health and beauty items), 12% from seasonal merchandise (such as toys, greeting cards, decorations, and gardening supplies), 7% from home products (for example, kitchen supplies, small appliances, and cookware), and 4% from basic apparel. Stores average roughly 7,400 square feet, and about 75% of Dollar General locations are in towns of 20,000 or fewer people. The firm emphasizes value, with most of its items sold at everyday low prices of $5 or less.
Read more on DG →